البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
SUMATRIPTAN AS SUCCINATE
GLAXO SMITH KLINE (ISRAEL) LTD
N02CC01
SOLUTION FOR INJECTION
SUMATRIPTAN AS SUCCINATE 6 MG / 0.5 ML
S.C
Required
GLAXO OPERATIONS (UK) LIMITED
SUMATRIPTAN
SUMATRIPTAN
Subcutaneous Injection is indicated for the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache.Imitrex should only be used where there is a clear diagnosis of migraine or cluster headache.
2022-02-28
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed according to a physician's prescription only IMITREX INJECTION Solution For Injection 6 mg/0.5 ml Each 0.5 ml pre-filled syringe contains: SUMATRIPTAN (AS SUCCINATE) 6 MG For the list of inactive and allergenic ingredients in the preparation, see section 6 “Additional information” and in section 2 “Important information about some of the ingredients of the medicine”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have any other questions, refer to the physician or the pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them even if it seems to you that their medical condition is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? Imitrex Subcutaneous Injection is indicated for the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache. Imitrex Injection should only be used where there is a clear diagnosis of migraine or cluster headache. Migraine and cluster headache symptoms may be caused by the temporary widening of blood vessels in the head. Imitrex Injection is believed to reduce the widening of these blood vessels. This in turn helps to take away the headache and relieve other symptoms such as nausea or vomiting and sensitivity to light and sound. THERAPEUTIC GROUP Analgesics: triptans - selective 5-HT 1 receptor agonists. 2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE: • IF YOU ARE SENSITIVE (ALLERGIC) to sumatriptan, or to any of the additional ingredients contained in the medicine (listed in section 6). • IF YOU HAVE A HEART PROBLEM such as narrowing of the arteries (ischaemic heart disease) or chest pains (angina) , or have already had a heart attack. • IF YOU HAVE CIRCULATION PROBLEMS IN YOUR LEGS that cause cramp-like pains when you walk (peripheral vascular disease) . • IF YOU HAVE HAD A STROKE or a اقرأ الوثيقة كاملة
Page 1 of 11 IMITREX INJECTION SUMMARY OF PRODUCT CHARACTERISTICS 1. TRADE NAME OF THE MEDICINAL PRODUCT IMITREX INJECTION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe contains 6 mg of sumatriptan base, as the succinate salt, in an isotonic solution of 0.5 ml. For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Pre-filled syringes for use in conjunction with an auto injector for subcutaneous injection. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Subcutaneous Injection is indicated for the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache.Imitrex should only be used where there is a clear diagnosis of migraine or cluster headache. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Imitrex Injection should not be used prophylactically. The recommended dose of Imitrex should not be exceeded. It is recommended to start the treatment at the first sign of a migraine headache or associated symptoms such as nausea, vomiting or photophobia. It is equally effective at whatever stage of the attack it is administered. The efficacy of sumatriptan is independent of the duration of the attack when starting treatment. Administration during a migraine aura prior to other symptoms occurring may not prevent the development of a headache. Imitrex Injection should be injected subcutaneously using an auto-injector. Patients should be advised to observe strictly the instruction leaflet for the Imitrex auto-injector especially regarding the safe disposal of syringes and needles. MIGRAINE: Page 2 of 11 ADULT_: _ The recommended adult dose of Imitrex is a single 6mg subcutaneous injection. If a patient does not respond to the first dose of sumatriptan, a second dose should not be taken for the same attack. In these cases the attack can be treated with paracetamol, acetylsalicylic acid, or non-steroidal anti-inflammatory drugs. Sumatriptan injection may be taken for subsequent attacks. If the patient has responded to the first dose, but the sympto اقرأ الوثيقة كاملة